We are live on
!
Find out more
Temasek Holdings Portfolio holdings
AUM
$30.5B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$17.2B
AUM Growth
-$1.83B
(-9.6%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-8.7%
Top 10 Holdings %
Top 10 Hldgs %
69.28%
Holding
65
New
3
Increased
3
Reduced
10
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$127M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$42.9M |
| 3 |
BP
BP
|
+$26.1M |
| 4 |
AC Immune
ACIU
|
+$12.8M |
| 5 |
COUP
Coupa Software Incorporated
COUP
|
+$929K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.15B |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$110M |
| 3 |
Illumina
ILMN
|
+$73.1M |
| 4 |
JD.com
JD
|
+$65.1M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.18% |
| 2 | Communication Services | 20.05% |
| 3 | Healthcare | 14.09% |
| 4 | Financials | 11.93% |
| 5 | Materials | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alibaba
BABA
$270B
| $4.78B | 27.78% |
28,988,503
-6,506,786
| -18% | -$1.15B |
|
2
Lumen
LUMN
$6.64B
| $2.61B | 15.19% |
123,201,207
| – | – |
|
3
Gilead Sciences
GILD
$161B
| $859M | 5% |
11,125,816
| – | – |
|
|
INFO
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $802M | 4.66% |
14,861,018
| – | – |
|
5
Visa
V
$672B
| $646M | 3.76% |
4,300,992
| – | – |
|
6
PayPal
PYPL
$49.5B
| $535M | 3.11% |
6,091,124
| – | – |
|
|
FTSI
7
DELISTED
FTS International, Inc. Common Stock
FTSI
| $491M | 2.85% |
2,080,857
| – | – |
|
|
UNVR
8
DELISTED
Univar Solutions Inc.
UNVR
| $432M | 2.51% |
14,078,012
| – | – |
|
|
ONC
9
BeOne Medicines Ltd
ONC
$33.8B
| $391M | 2.27% |
2,270,100
| – | – |
|
10
Thermo Fisher Scientific
TMO
$209B
| $367M | 2.13% |
1,503,087
| – | – |
|
11
DuPont de Nemours
DD
$18.7B
| $361M | 2.1% |
2,219,267
-189,282
| -8% | -$32.6M |
|
12
Virtu Financial
VIRT
$5.21B
| $345M | 2.01% |
16,880,503
| – | – |
|
13
Mastercard
MA
$472B
| $321M | 1.87% |
1,440,714
| – | – |
|
14
Trip.com Group
TCOM
$27.7B
| $270M | 1.57% |
7,256,928
| – | – |
|
|
RDS.B
15
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $247M | 1.44% |
3,487,948
+619,081
| +22% | +$42.9M |
|
|
WP
16
DELISTED
Worldpay, Inc.
WP
| $246M | 1.43% |
2,426,186
| – | – |
|
|
17
BioMarin Pharmaceuticals
BMRN
$11.4B
| $230M | 1.34% |
2,372,712
-1,100,000
| -32% | -$110M |
|
18
ZTO Express
ZTO
$18.3B
| $202M | 1.17% |
12,176,750
| – | – |
|
19
Boeing
BA
$167B
| $195M | 1.14% |
525,636
| – | – |
|
20
PPG Industries
PPG
$26B
| $189M | 1.1% |
1,727,645
| – | – |
|
|
NFX
21
DELISTED
Newfield Exploration
NFX
| $178M | 1.04% |
6,181,546
-144,500
| -2% | -$4.06M |
|
22
Antero Resources
AR
$11B
| $173M | 1.01% |
9,755,618
| – | – |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
| $171M | 0.99% |
1,226,630
-278,695
| -19% | -$35M |
|
|
GRA
24
DELISTED
W.R. Grace & Co.
GRA
| $156M | 0.91% |
2,187,501
| – | – |
|
|
TRQ
25
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $150M | 0.87% |
7,080,700
-240,688
| -3% | -$6.01M |
|
Similar funds
Temasek Holdings's Q3 2018 Portfolio in Review
As of Q3 2018, Temasek Holdings held 65 positions worth $17.2B, down 9.6% from $19B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Temasek Holdings withdrew a net $1.5B in Q3 2018, closing 10 positions and reducing 10 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Temasek Holdings opened a new position in Farfetch Limited Class A Ordinary Shares worth $122M.
- Temasek Holdings's largest Q3 2018 buy was Farfetch Limited Class A Ordinary Shares: 4,470,415 shares worth $122M.
- Temasek Holdings added most to Royal Dutch Shell PLC ADS Class B in Q3 2018, an estimated $42.9M increase.
- Temasek Holdings's biggest Q3 2018 reduction was Alibaba, cutting an estimated $1.15B.
- Temasek Holdings fully exited Vertex Pharmaceuticals in Q3 2018, selling an estimated $41.6M.
- Temasek Holdings's ten largest holdings make up 69% of its $17.2B portfolio in Q3 2018.
- Temasek Holdings opened 3 new positions and closed 10 in Q3 2018.
- Temasek Holdings's portfolio value fell 9.6% quarter-over-quarter to $17.2B.
Based on Temasek Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.